A nurse is transcribing a client’s prescription for erythromycin 500 mg four times per day. Which of the following information should the nurse clarify with the provider?
Medication
Dosage
Route
Time
The Correct Answer is C
Choice A reason: Erythromycin is specified, so the medication is clear. No ambiguity exists here for clarification. Scientifically, drug identity is explicit, and errors arise elsewhere, making this unnecessary to question unless a different antibiotic was intended, which isn’t suggested.
Choice B reason: Dosage (500 mg) is precise, with no range or units needing clarification. Scientifically, this is a standard erythromycin dose, aligning with therapeutic norms for infections, leaving little room for error unless misheard, which isn’t indicated.
Choice C reason: Route (e.g., oral, IV) isn’t stated, critical for erythromycin, as administration affects bioavailability and efficacy. Scientifically, unclear delivery risks under- or overdosing, necessitating provider clarification to ensure safe, effective treatment per pharmacological standards.
Choice D reason: Time (four times daily) is clear, aligning with erythromycin’s pharmacokinetics for steady levels. Scientifically, frequency is unambiguous, requiring no clarification unless intervals were vague, which they aren’t, making this less urgent than route.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is B
Explanation
Choice A reason: Budesonide prevents, not rescues, asthma attacks; rescue inhalers like albuterol are used instead. This shows misunderstanding of its controller role in management.
Choice B reason: Rinsing after budesonide, a corticosteroid, prevents oral thrush by removing residue. This reflects correct understanding of side effect prevention in asthma therapy.
Choice C reason: Timing budesonide to meals and bedtime isn’t standard; it’s typically twice daily. This indicates confusion about its preventive, not situational, use.
Choice D reason: Pre-exercise use fits rescue inhalers, not budesonide, which builds long-term control. This misapplies its purpose, showing a lack of asthma management grasp.
Correct Answer is D
Explanation
Choice A reason: Swallowing isn’t an option for chewable isosorbide; it’s designed for sublingual absorption. This advice is incorrect and won’t address vasodilatory headache effects.
Choice B reason: Discontinuing isosorbide risks angina exacerbation in cardiac patients. Headaches are tolerable side effects, so stopping isn’t advised without provider input.
Choice C reason: Empty stomach intake doesn’t reduce isosorbide’s vasodilatory headaches. Timing doesn’t alter its nitrate-induced vessel dilation, making this ineffective advice.
Choice D reason: Headaches from isosorbide’s vasodilation typically subside with tolerance over time. This reassures the client, aligning with expected nitrate therapy adaptation.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.